Zacks Research Cuts Earnings Estimates for Molina Healthcare

Molina Healthcare, Inc (NYSE:MOH) – Investment analysts at Zacks Research decreased their Q3 2026 earnings per share estimates for Molina Healthcare in a report issued on Wednesday, August 12th. Zacks Research analyst Team now forecasts that the company will earn $0.72 per share for the quarter, down from their previous estimate of $1.07. Zacks Research currently has a “Strong-Buy” rating on the stock. The consensus estimate for Molina Healthcare’s current full-year earnings is $5.29 per share. Zacks Research also issued estimates for Molina Healthcare’s Q4 2026 earnings at $0.70 EPS, Q1 2027 earnings at $2.53 EPS, Q2 2027 earnings at $2.22 EPS, Q4 2027 earnings at $2.87 EPS, FY2027 earnings at $10.05 EPS, Q1 2028 earnings at $2.21 EPS and FY2028 earnings at $11.94 EPS.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.12. The firm had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The business’s quarterly revenue was down 4.8% compared to the same quarter last year. During the same period last year, the company earned $5.48 EPS.

Several other equities analysts have also issued reports on MOH. JPMorgan Chase & Co. boosted their price objective on Molina Healthcare from $169.00 to $191.00 and gave the company a “neutral” rating in a research report on Monday, June 8th. Barclays cut their price objective on Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating for the company in a report on Friday, July 24th. Jefferies Financial Group set a $230.00 price objective on Molina Healthcare in a research note on Tuesday, July 14th. Robert W. Baird increased their price target on shares of Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $129.00 target price on shares of Molina Healthcare in a report on Friday, April 24th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $202.44.

Molina Healthcare Trading Down 0.0%

MOH opened at $206.00 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. Molina Healthcare has a twelve month low of $121.06 and a twelve month high of $244.89. The firm’s fifty day moving average is $210.56 and its two-hundred day moving average is $177.84. The firm has a market cap of $10.75 billion, a PE ratio of -1,144.38, a price-to-earnings-growth ratio of 29.52 and a beta of 0.75.

Institutional Trading of Molina Healthcare

Several institutional investors have recently modified their holdings of the business. Manning & Napier Advisors LLC bought a new stake in shares of Molina Healthcare in the 2nd quarter valued at about $152,339,000. Algert Global LLC raised its holdings in Molina Healthcare by 35.5% during the 2nd quarter. Algert Global LLC now owns 52,240 shares of the company’s stock worth $11,947,000 after purchasing an additional 13,690 shares during the last quarter. Asset One Wealth Management LLC bought a new stake in shares of Molina Healthcare in the 2nd quarter valued at $317,000. Cibc World Market Inc. acquired a new stake in shares of Molina Healthcare during the second quarter worth $1,719,000. Finally, Sanctuary Advisors LLC acquired a new position in Molina Healthcare in the second quarter valued at $871,000. Institutional investors own 98.50% of the company’s stock.

More Molina Healthcare News

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Zacks Research raised multiple earnings forecasts and maintained a “Strong-Buy” rating. Estimates increased for Q4 2026 EPS to $0.70 from $0.53, Q1 2027 EPS to $2.53 from $1.60, Q2 2027 EPS to $2.22 from $1.82, Q4 2027 EPS to $2.87 from $2.00, FY2027 EPS to $10.05 from $7.61, Q1 2028 EPS to $2.21 from $1.12 and FY2028 EPS to $11.94 from $9.76. The upgrades point to expectations for a stronger earnings recovery beyond the current year.
• Positive Sentiment: Zacks also modestly increased its FY2026 EPS estimate to $5.28 from $5.22, broadly in line with the $5.29 consensus estimate. Molina Healthcare analyst estimate coverage
• Positive Sentiment: Recent coverage highlighted Medicaid clarity and Molina’s robust second-quarter results. Management previously raised its minimum 2026 adjusted earnings outlook to $5.25 per share from $5.00, helping support a rebound in sentiment after the stock’s post-earnings selloff. Molina Healthcare surged on Medicaid clarity and robust results
• Positive Sentiment: Investor Michael Burry reportedly added to his Molina position at approximately $198, providing a notable sentiment signal for the managed-care stock. Michael Burry adds to Molina Healthcare position
• Neutral Sentiment: The latest analyst revisions are mixed: Zacks cut Q3 2026 EPS to $0.72 from $1.07 and reduced Q2 2028 EPS to $2.30 from $2.60, even as it raised most other forward estimates.
• Negative Sentiment: Molina continues to face higher medical costs and a weaker revenue outlook. Its latest quarterly revenue declined 4.8% year over year, while management has characterized 2026 as a challenging margin year.
• Negative Sentiment: Recent insider activity was net negative, with several executives selling shares, although one insider made a purchase. These transactions may temper enthusiasm but are not necessarily indicative of company fundamentals. Molina Healthcare earnings outlook and trading activity

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.